European Medicines Agency recommends marketing authorisation for Kaftrio for cystic fibrosis

Kaftrio shows clinically significant improvement in lung function and decrease of sweat chloride.
Kaftrio shows clinically significant improvement in lung function and decrease of sweat chloride.